SIM
RGNX icon

SummerHaven Investment Management’s Regenxbio RGNX Stock Holding History

SummerHaven Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,298
Closed -$426K – 253
2023
Q2 		$426K Sell
21,298
-6,205
-23% -$120K 0.27% 175
2023
Q1 		$520K Buy
27,503
+848
+3% +$18.8K 0.3% 183
2022
Q4 		$605K Buy
26,655
+519
+2% +$11.7K 0.36% 175
2022
Q3 		$691K Buy
+26,136
New +$775K 0.48% 117

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SummerHaven Investment Management's RGNX Position: Q3 2023 in Review

SummerHaven Investment Management sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 21,298 shares — an estimated $426K sold.

SummerHaven Investment Management first reported a position in RGNX in Q3 2022 and held it in 4 quarters. The position peaked at $691K in Q3 2022. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

  • SummerHaven Investment Management reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
  • SummerHaven Investment Management sold 21,298 Regenxbio shares in Q3 2023, an estimated $426K.
  • SummerHaven Investment Management first reported a position in Regenxbio in Q3 2022 and held it in 4 quarters.
  • SummerHaven Investment Management's Regenxbio position peaked at $691K in Q3 2022.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on SummerHaven Investment Management's 13F filing for Q3 2023, filed 13 Oct 2023.